Dr. John Barbieri, MD

NPI: 1972921955
Total Payments
$77,019
2021 Payments
$19,339
Companies
2
Transactions
5
Medicare Patients
1,456
Medicare Billing
$76,819

Payment Breakdown by Category

Other$76,929 (99.9%)
Education$89.95 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $76,929 4 99.9%
Education $89.95 1 0.1%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $76,929 4 $0 (2021)
Janssen Biotech, Inc. $89.95 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2021 $19,339 1 PFIZER INC. ($19,339)
2020 $57,589 3 PFIZER INC. ($57,589)
2018 $89.95 1 Janssen Biotech, Inc. ($89.95)

All Payment Transactions

5 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/30/2021 PFIZER INC. Grant Cash or cash equivalent $19,339.46 General
12/30/2020 PFIZER INC. Grant Cash or cash equivalent $25,813.61 General
12/30/2020 PFIZER INC. Grant Cash or cash equivalent $24,047.88 General
01/01/2020 PFIZER INC. Grant Cash or cash equivalent $7,727.78 General
08/31/2018 Janssen Biotech, Inc. Tremfya (Drug) Education In-kind items and services $89.95 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 117 252 $48,382 $8,125
2022 6 108 118 $33,861 $5,789
2021 8 451 682 $71,658 $19,316
2020 10 780 1,234 $118,710 $43,589
Total Patients
1,456
Total Services
2,286
Medicare Billing
$76,819
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 37 $14,966 $2,772 18.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 38 51 $14,004 $2,517 18.0%
17110 Destruction of skin growth, 1-14 growths Office 2023 19 28 $8,086 $1,409 17.4%
17000 Destruction of precancer skin growth, 1 growth Office 2023 16 24 $5,704 $1,003 17.6%
11102 Biopsy of related skin growth, first growth Office 2023 11 13 $2,052 $258.99 12.6%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 11 99 $3,570 $166.08 4.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 21 26 $10,359 $2,063 19.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 32 34 $9,130 $1,716 18.8%
17110 Destruction of skin growth, 1-14 growths Office 2022 16 17 $4,699 $719.89 15.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $4,038 $575.07 14.2%
17000 Destruction of precancer skin growth, 1 growth Office 2022 13 15 $3,360 $469.77 14.0%
11102 Biopsy of related skin growth, first growth Office 2022 14 14 $2,275 $245.26 10.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 143 147 $24,250 $6,910 28.5%
17000 Destruction of skin growth Office 2021 93 101 $12,513 $3,214 25.7%
17110 Destruction of up to 14 skin growths Office 2021 47 50 $9,783 $3,019 30.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 29 $7,653 $1,823 23.8%
11102 Tangential biopsy of single skin lesion Office 2021 33 34 $5,830 $1,151 19.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 18 18 $4,629 $1,098 23.7%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 30 32 $3,255 $1,062 32.6%
17003 Destruction of 2-14 skin growths Office 2021 61 271 $3,745 $1,039 27.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 164 180 $33,156 $11,550 34.8%
17110 Destruction of up to 14 skin growths Office 2020 92 108 $19,785 $8,077 40.8%
17000 Destruction of skin growth Office 2020 138 164 $18,287 $5,888 32.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 102 120 $14,968 $5,583 37.3%
11102 Tangential biopsy of single skin lesion Office 2020 66 69 $11,273 $4,344 38.5%

About Dr. John Barbieri, MD

Dr. John Barbieri, MD is a Dermatology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1972921955.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Barbieri, MD has received a total of $77,019 in payments from pharmaceutical and medical device companies, with $19,339 received in 2021. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Grant" ($76,929).

As a Medicare-enrolled provider, Barbieri has provided services to 1,456 Medicare beneficiaries, totaling 2,286 services with total Medicare billing of $76,819. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Other Specialties Dermatology
  • Location Boston, MA
  • Active Since 04/07/2014
  • Last Updated 06/17/2021
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1972921955

Products in Payments

  • Tremfya (Drug) $89.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Boston